Omnipaque Shortage? Secure Backup Supply Fast.

Omnipaque is the brand name for iohexol, a nonionic iodinated contrast media used across radiologic imaging — CT, angiography, urography, and a range of other diagnostic procedures. As a workhorse contrast agent in hospitals and imaging centers, iohexol is essential to daily imaging workflows, and disruptions to its availability are felt quickly across radiology departments.

Iohexol supply has been constrained industry-wide for several reasons. Global manufacturing of iodinated contrast media is concentrated among a small number of producers, and upstream active pharmaceutical ingredient supply has experienced repeated ripple effects. Contrast media have appeared on FDA shortage lists in recent years, and steadily rising imaging volumes have added pressure to an already tight market. The result is intermittent gaps in specific Omnipaque strengths and bottle sizes — most commonly the higher-concentration 300 and 350 mgI/mL configurations used for CT.

Our distribution network helps fill those gaps. We work directly with hospitals, imaging centers, and ambulatory surgical centers to provide DSCSA-compliant secondary supply of Omnipaque and alternate iohexol configurations. When primary contract channels run short, we source available NDCs, document each transaction with full pedigree, and offer strength or size substitutions when appropriate so imaging schedules can continue without interruption.